Agenda. A short introduction to Denmark. Background information about Faaborg Midtfyn Municipality. The NRR project. Our findings from the project
|
|
- Shanon Scott
- 5 years ago
- Views:
Transcription
1
2 Agenda A short introduction to Denmark Background information about Faaborg Midtfyn Municipality The NRR project Our findings from the project Future collaboration with Japan
3 Agenda A short introduction to Denmark Background information about Faaborg Midtfyn Municipality The NRR project Our findings from the project Future collaboration with Japan
4 A short introduction to Denmark Japan Population: 128 mio. Over 65 years of age: 19,7% Ranks 2nd for countries with the highest proportion of citizens over 65 Denmark Population: 5,4 mio. Over 65 years of age: 15,1% Ranks 22nd over countries with the highest proportion of citizens over 65
5 A short introduction to Denmark
6 A short introduction to Denmark Central Jutland Region IT-systems for healthcare sectors Pervasive healthcare North Jutland Region Develop medicine and medtech Intelligent assistive devices Automation and IT support functions South Jutland Region Intelligent assistive devices Telemedicine treatments Automation Health-IT-systems The Capital Region of Denmark Develop medicine and medtech Diagnostics clinical research 6
7 A short introduction to Denmark Working conditions: Short working day High labour productivity level Requires: High level of trust in employees Self-organised workers Clear and well-defined goals from management Accept that mistakes can happen, and that they can be fixed Share information 7
8 A short introduction to Denmark
9 A short introduction to Denmark Tax pressure: High tax pressure based on income frame: 39% - 55% VAT on all goods: 25% Company tax rate: 25% Life conditions: Free education Government support while unemployed Free access to doctors and hospitals 9
10 A short introduction to Denmark For Healthcare sector it is common practice to use the triple bottom line when assessing new methods or technologies: Avoid increased cost (profit) Stimulate growth in local businesses (Environment) Increase quality of life and service for the citizens and staff (Community) 10
11 Agenda A short introduction to Denmark Background information about Faaborg Midtfyn Municipality The NRR project Our findings from the project Future collaboration with Japan
12 Faaborg-Midtfyn Municipality Facts: citizens (36.228) 637 km2 (12 km2) employees 80 departements 9 professional divisions 4staff units Member of Welfare Tech Administration budget Total budget: 44 billion JPY
13 Faaborg-Midtfyn Municipality The Care Division of FMK provide: Practical and personal aid to citizens in their own homes Care for citizens in ursing homes / care facilities Home nursing No. of elderly recieving care 400 in nursing homes 1916 receives home care 1243 receives home nursing No. of employees 1057 No. of students/trainees 45/126 No. of units 30 Budget Price nursing home 5 billion JPY JPY/ day Meals on wheels for retired citiziens
14 Faaborg-Midtfyn Municipality Our strategy We wish to create an eco system that will: Provide good care for our elderly Offer good working environment for our staff Utilize latest technologies Participate in developing new technologies and soloutions in collaboration with private companies
15 Faaborg-Midtfyn Municipality We have visited Japan twice: In 2011: Osaka Noboribetsu In 2014: Tokyo NEDO DOCOMO Local technology companies Fukuoka area Vice Mayor of Fukkuoka TMSUK
16 Agenda A short introduction to Denmark Background information about Faaborg Midtfyn Municipality The NRR project Our findings from the project Future collaboration with Japan
17 The NRR project The participating partners
18 The NRR project Two test facilities in the municipality: Aaløkkeparken, Broby Manager: Lise-Lotte Steengaard 48 appartments Nørrevænget 1, Gislev Manager: Merete Jørgensen 46 appartments
19 The NRR project Science and research Business and Private companies Social system And government? 19
20 The NRR project The project ran through different phases: Initial evaluation of technology Identify test parameters Design test At university laboratories At municipality facilities Choose test persons Install technology Educate staff Carry out tests in two segments
21 Agenda A short introduction to Denmark Background information about Faaborg Midtfyn Municipality The NRR project Our findings from the project Future collaboration with Japan
22 Findings from NRR project Some elements of Danish care system are hard to explain. For example: The way we measure product quality in the Danish Health care system The features of an entirely publicly funded system The way we divide labor between staff and management
23 Findings from NRR project The planning of tests are quite different in Denmark and Japan. This influence: The types of results we reach The way we actually carry out the tests The amount of instruction neccesary for the staff
24 Findings from NRR project Danish people participate in special way: We often speak our minds We are very focused on solving problems We also have high ideals Our elderly people and staff like to particiapte in these types of test
25 Findings from NRR project Our understanding of authorities: A specialists opinion (eg. A doctor) is important, but not the ultimate truth We put faith in the opinions of those that actually carry out the work Caregivers Nurses The foremost expert is actually the patient/ elderly person
26 Findings from NRR project The percpetion of elderly people in Denmark: They should stay as long as possible in their own home being independent Activity is encouraged as much as possible Dignity in the late years is also a public task
27 Findings from NRR project In conclusion: New insights Evaluation of our model New ideas for the future Developed our own organization
28 We would like to thank:
29 Agenda A short introduction to Denmark Background information about Faaborg Midtfyn Municipality The NRR project Our findings from the project Future collaboration with Japan
30 Future collaboration with Japan Happy to test relevant technologies This can include: Provide manpower for test Provide access to care facilities Help plan and carry out test Provide sincere feedback on product relevance
31 Future collaboration with Japan Our goals for ourselves are to: Generate new knowledge Better understanding of our own way of providing care Expand our understanding of how technology can shape the future in care giving Find new products that can help us Save money Create a better working environment for our staff Provide better care / higher level of user satisfaction and independence
32 Future collaboration with Japan Our goals for our collaboration partners are to: Create a good place for Japanese companies to establish business or adapt their products through: Close collaboration with municipaliy Close to all major transportation Good availability of highly educated people
33 Thank you for your attention Michael Bech Petersen Manager of Digitization and Healthcare Technology Division Municipality of Faaborg-Midtfyn Denmark 2015 Powered by
Bupa Future Survey Series
Bupa Future Survey Series March 2017 The future of private health insurance: Why insurers need to play a leading role in the innovation and transformation of Australia's health and care system The examines
More informationGuidelines for cost analyses of new medicines and indications in the hospital sector
Guidelines for cost analyses of new medicines and indications in the hospital sector 1 Table of contents 1. Introduction... 3 2. Guidelines for cost analyses of new medicines and new indications in the
More informationINSURANCE FOR THE HEALTHCARE INDUSTRY
INSURANCE FOR THE HEALTHCARE INDUSTRY YOUR WORLD, OUR KNOWLEDGE In your world, the patient comes first. Every minute of every day, you are focused on them. In our world, you come first. For more than half
More information1. Introduction Executive Summary Market Survey Evaluation of Product/Market Suitability SWOT Analysis...
Date June 2014 1. Introduction... 2 2. Executive Summary... 2 3. Market Survey... 3 4. Evaluation of Product/Market Suitability... 5 5. SWOT Analysis... 6 The Trade Council is pleased to submit a brief
More informationEthical Rules for Collaboration between Patient Groups, etc. and the Pharmaceutical Industry
Ethical Rules for Collaboration between Patient Groups, etc. and the Pharmaceutical Industry 1. Purpose The ethical rules create a framework for collaboration between the pharmaceutical industry and patient
More informationStandardisation of Health and Social Services
Standardisation of Health and Social Services Position of the European Social Insurance Platform (ESIP) FINAL 14 July 2016 - 2 - About the European Social Insurance Platform (ESIP) The European Social
More informationNATIONAL SOCIAL REPORT Estonia
NATIONAL SOCIAL REPORT 2014 Estonia Table of contents Introduction... 3 A decisive impact on the eradication of poverty and social exclusion... 3 Recent reforms in social inclusion policies... 4 People
More informationEthical Rules for Collaboration between Patient Organisations, etc., and the Pharmaceutical Industry
Ethical Rules for Collaboration between Patient Organisations, etc., and the Pharmaceutical Industry Art. 1. Purpose The ethical rules provides a framework for collaboration between the pharmaceutical
More informationOUTLINE Health Insurance System National Health Insurance Employee s Health Insurance Gakkenbai, Gakkensai Tokyo Tech Webpage & Health Support Center
Tokyo Institute of Technology Hosted by the Office of Education and International Cooperation Japanese Medical System Daily Life Support Orientation For International Students and Researchers July 6, 2018
More informationREPORT ON DENMARK S APPLICATION OF THE COMMISSION DECISION OF 20 DECEMBER 2011 ON SERVICES OF GENERAL ECONOMIC INTEREST
Logo: Ministry of Business and Growth Denmark REPORT ON DENMARK S APPLICATION OF THE COMMISSION DECISION OF 20 DECEMBER 2011 ON SERVICES OF GENERAL ECONOMIC INTEREST June 2016 2/14 CONTENTS Introduction
More informationBriefing: The EU Japan EPA and the European medical device market
Briefing: The EU Japan EPA and the European medical device market In 2017 the EU and Japan signed the EU-Japan Economic Partnership Agreement. This trade agreement, which is expected to become effective
More informationDRG in Europe, esp. Germany
DRG in Europe, esp. Germany System overview and consequences for coding--- DRG-konferansen 5. 6. mars 2007 Oslo Dr. Michael Wilke Agenda 1 Rambøll Management 2 The German HealthCare System 3 4 DRG in Europe
More informationMETHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)
METHODOLOGY NOTES TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) Country of Disclosure: Belgium Year of Disclosure: 2017 for 2016
More informationFREQUENTLY ASKED QUESTIONS SUNSHINE ACT
FREQUENTLY ASKED QUESTIONS SUNSHINE ACT 1. What exactly is the obligation of transparency? The obligation of transparency imposes amongst others pharmaceutical and medical devices companies, both Belgian
More informationINTERNATIONAL HEALTH SYSTEMS: THE ASIAN (TAIWAN, JAPAN, SINGAPORE,)
INTERNATIONAL HEALTH SYSTEMS: THE ASIAN (TAIWAN, JAPAN, SINGAPORE,) Presented by: Ms. Nuanthip Tangsitchanakun 5749173 Ms. Nan Nin Shwe Yi Lin 5849104 HEATH CARE SYSTEMS JAPAN IN OVERVIEW OF JAPAN HEALTHCARE
More informationFREQUENTLY ASKED QUESTIONS SUNSHINE ACT
FREQUENTLY ASKED QUESTIONS SUNSHINE ACT 1. What exactly is the obligation of transparency? The obligation of transparency imposes pharmaceutical and medical devices companies, both Belgian and foreign,
More informationBERMUDA HEALTH INSURANCE DEPARTMENT ANNUAL REPORT
BERMUDA HEALTH INSURANCE DEPARTMENT ANNUAL REPORT YOUR HEALTH MATTERS Welcome to the Health Insurance Department s first annual report for policyholders of FutureCare and the Health Insurance Plan ( HIP
More informationReporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018
Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca Österreich GmbH Landstraßer Hauptstraße 1A, 1030 Wien Firmenbuch FN 51184x, HG Wien Contents
More informationScope of Practice & Compensation Report for the Regulatory Profession
2014 Scope of Practice & Compensation Report for the Regulatory Profession 2014 Scope of Practice & Compensation Report for the Regulatory Profession 1 Contents Introduction... 2 About RAPS... 2 The Survey:
More informationMETHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)
METHODOLOGY NOTES TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) Country of Disclosure: Ireland Year of Disclosure: 2018 for 2017
More informationLithuania. How does the country rank in the EU? Health. Overall Findings. Need Lithuania has a high need for policy reform, assessed by the experts
Findings by Country How does the country rank in the EU? Health Poverty Prevention Best Median Worst Social Cohesion and Non-discrimination Equitable Education Labour Market Access Social Justice Index
More informationIICCI Short Market Overviews. The Healthcare Industry in India
The Healthcare Industry in India 1. The Healthcare Industry In India healthcare is delivered through both the public sector and private sector. The public healthcare system consists of healthcare facilities
More informationWELCOME TO GROUP CRITICAL ILLNESS
WELCOME TO GROUP CRITICAL ILLNESS THANK YOU Thank you for choosing Canada Life Group Insurance Thank you for choosing us to provide Group Critical Illness cover for you and your employees. We provide more
More informationMETHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)
METHODOLOGY NOTES TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) Country of Disclosure: Austria Year of Disclosure: 2018 for 2017
More informationLegal grounds Act LXV of 1990 on Local Governments (hereinafter referred to as Local Government Act)
Magdolna Berenyi Financial audit of local government institutions providing services to the homeless in Hungary Homelessness terms The homelessness has existed for thousand years and since the beginning
More informationBirth Age
Social security system supporting people throughout their lifetime Birth Age 6 12 15 18 20 40 50 60 70 75 Before school School period Child-raising/working period After retirement [Health/medical care]
More informationUniversal and Equal Access to Health-care Services. Štefan Krajčík Slovak Medical University Bratislava, Slovakia
Universal and Equal Access to Health-care Services Štefan Krajčík Slovak Medical University Bratislava, Slovakia Universal and Equal Access to Health-care Services Member States of the World Health Organization
More informationMETHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)
METHODOLOGY NOTES TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) Country of Disclosure: United Kingdom Year of Disclosure: 2017
More informationHong Kong Women Professionals & Entrepreneurs Association (HKWPEA) Public Affairs Committee
Hong Kong Women Professionals & Entrepreneurs Association (HKWPEA) Public Affairs Committee Response Paper to the Review of Enhancement of Retirement Protection as proposed by the Commission on Poverty
More informationAstraZeneca AB Södertälje. Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2015 Data in 2016
AstraZeneca AB 556011-7482 151 85 Södertälje Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2015 Data in 2016 Contents 1. Introduction... 4 Approach to disclosure
More informationINTERIM REPORT Q2 JANUARY JUNE 2017
1 INTERIM REPORT Q2 JANUARY JUNE 2017 WE LIVE LONGER THAN EVER BEFORE BUT FEW OF US REMAIN COMPLETELY HEALTHY THROUGHOUT LIFE In the last 25 years, medication has increased significantly among the elderly.
More informationChapter 2 Overview of Social Security in Japan
Security in Japan 2014 2.1 History of the social security system in Japan 2.1.1 Pre-Modern Era (before 1868) As with other countries, the source of social security in Japan could be found in charity-oriented
More informationA Discrete Event Simulation Model for Outpatient Appointment Scheduling
A Discrete Event Simulation Model for Outpatient Appointment Scheduling Michelle Alvarado, PhD Mark Lawley, PhD Yan Li, PhD Industrial and Systems Engineering, Texas A&M University New York Academy of
More informationHealthcare System Innovation for Aging Society -Issues and Direction-
Healthcare System Innovation for Aging Society -Issues and Direction- APEC Life Sciences Innovation Forum Health Financing Mechanisms & Options Sep. 19, 2010 Prof. Akira Morita University of Tokyo 2010
More informationMedicines for Europe (MFE) HCP/HCO/PO Disclosure Transparency Requirements. Samsung Bioepis Methodology Note
Medicines for Europe (MFE) HCP/HCO/PO Disclosure Transparency Requirements Samsung Bioepis Methodology Note 1 Contents 1. Overview of the MFE Requirements 2. Decisions 3. Submission Requirements 4. Categories
More informationFinancial strategies for the healthcare industry
Financial strategies for the healthcare industry Financial strategies for the healthcare industry In an ever-changing industry, you need a financial partner who understands your unique needs and enables
More informationDANISH MINISTRY OF BUSINESS AND GROWTH
DANISH MINISTRY OF BUSINESS AND GROWTH REPORT ON DENMARK S APPLICATION OF THE COMMISSION DECISION OF 20 DECEMBER 2011 CONCERNING THE OPERATION OF SERVICES OF GENERAL ECONOMIC INTEREST (SGEI) June 2014
More informationCARING FOR YOUR SMALL BUSINESS. Off-Exchange 2018 Plans and Services for Groups With Up to 100 Employees
CARING FOR YOUR SMALL BUSINESS Off-Exchange 2018 Plans and Services for Groups With Up to 100 Employees SMALL GROUP PLANS AT A GLANCE EmblemHealth offers small group plans with the needs and budgets of
More informationInsurance Technology and Longevity Risk. Jennifer Li-Ling Wang Vice President of National Chenghgchi University Chairman of Fintech Research Center
Insurance Technology and Longevity Risk Jennifer Li-Ling Wang Vice President of National Chenghgchi University Chairman of Fintech Research Center The Impact of InsurTech WEF FinTech report in 2015 state
More informationCOMPANY. Product Summary From 1 April bupa.com.au
COMPANY Product Summary From 1 April 2017 bupa.com.au Bupa international private medical insurance is underwritten in Australia by Insurance Australia Limited ABN 11 000 016 722 (IAL), AFSL number 227681.
More informationHealthcare. The role of real estate. June 2014
1 Healthcare The role of real estate June 2014 2 Background 1. The British Property Federation (BPF) is the voice of real estate in the UK, representing businesses owning, managing and investing in real
More informationThe Impact of Future Healthcare Reform on MedTech Communications
J. Robert Paulson President & CEO NxThera, Inc. The Impact of Future Healthcare Reform on MedTech Communications Perspectives From an Early-Stage Medical Device Company The Impact of Future Healthcare
More informationBusiness Results for The First Half of FY2018 (April 1, 2018 September 30, 2018) November 1, 2018
Business Results for The First Half of FY2018 (April 1, 2018 September 30, 2018) November 1, 2018 Please be aware of the following: * The financial information provided on this material has been prepared
More informationAdding value to the Bancassurance Offer, Trends and Initiatives from an Assistance Company Perspective. Warsaw, 24th of October 2013
Adding value to the Bancassurance Offer, Trends and Initiatives from an Assistance Company Perspective Warsaw, 24th of October 2013 Table of contents 1. The Assistance Concept 2. Added Value for Bancassurance
More informationMedTech Europe Code of Ethical Business Practice. Disclosure Guidelines
MedTech Europe Code of Ethical Business Practice Disclosure Guidelines Final version: 13 September 2016 Table of Contents Preamble... 2 Chapter 1: Applicability of these Guidelines... 3 1. Scope... 3 2.
More informationMethodology for Compliance with the Research-Based Pharmaceutical Industry (LIF) Disclosure Code
Methodology for Compliance with the Research-Based Pharmaceutical Industry (LIF) Disclosure Code Date Published: 31 May 2017 Index Annex 1: The disclosure in accordance with the Schedule 2 Template Annex
More informationThis little Piggy likes questions! FAQ Guide
This little Piggy likes questions! FAQ Guide A guide to some of the most frequently asked questions related to health spending accounts and some additional tips smart folks should know. Table of Contents
More informationEducation, training, life-long learning and capacity-building
Education, training, life-long learning and capacity-building 1. In your country/region, how is the right to education, training, life-long learning and capacity building in
More informationGilead Transparency Reporting Methodological Note
Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers
More informationReporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018
Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca Bulgaria EOOD Registration number 201340239 36 Dragan Tsankov, Bulgaria, Sofia1057 Contents
More informationMethodology for Compliance with the ABPI Disclosure Code. Introduction Page 1. General Comments Page 2. Indirect Transfers of Value Page 3
Date Published: 15 th March 2017 Version: 20 (December 4, 2015) Index Methodology for Compliance with the ABPI Disclosure Code Introduction Page 1 General Comments Page 2 Indirect Transfers of Value Page
More informationARPIM HCP/HCO DISCLOSURE CODE
ARPIM HCP/HCO DISCLOSURE CODE ARPIM CODE ON THE DISCLOSURE OF SPONSORSHIPS AND OTHER TRANSFERS OF VALUE FROM PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)
More informationLong-term care Dilemmas concerning sustainable financing (Ljubljana, November 2014) 1
Long-term care Dilemmas concerning sustainable financing (Ljubljana, 18-19 November 2014) 1 Heino Jespersen The National Social Appeals Board This paper briefly describes the organisation and funding of
More informationSESSIONS MASTERCLASS A - 29/01/2018. Healthcare Insurance Forum
MASTERCLASS A - 29/01/2018 Building a Winning Digital Strategy for your Organisation 08:00-12:00 The world is increasingly connected through technology changing the way people think and the way business
More informationGilead Transparency Reporting Methodological Note
Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers
More informationIBFD Course Programme Transfer Pricing: Financial Services Industry Masterclass
IBFD Course Programme Transfer Pricing: Financial Services Industry Overview and Learning Objectives Digitalization has changed and will continue to change business models. This will impact the global
More informationReporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018
AstraZeneca Eesti OÜ Reg. kood 11733875 Järvevana tee 9 11314 Tallinn Estonia Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Contents 1. Introduction...
More informationGilead Transparency Reporting Methodological Note
Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers
More informationHealth System and Policies of China
of China Yang Cao, PhD Associate Professor China Pharmaceutical University Nanjing, China Transformation of Healthcare Delivery in China Medical insurance 1 The timeline of the medical and health system
More informationLIKE YOU, WE RE EXPERTS IN OUR FIELD
Administered by MARITIME SHIPPING LIKE YOU, WE RE EXPERTS IN OUR FIELD Insured by Health nsurance Raffles Health Insurance Pte Ltd, (Company Registration No: 200413569G), 133 Middle Road, Bank of China
More informationDr. Robert Riehle Jr. Wofford College 2/24/10
Dr. Robert Riehle Jr. Wofford College 2/24/10 Wofford Healthcare Symposium Our current system and its need to change Financing of the delivery system Components of an ideal delivery system What change
More informationGLOBAL HEALTH PARTNER Q4 REPORT Daniel Öhman, CEO Tobias Linebäck, CFO and Dep. CEO
REPORT Daniel Öhman, CEO Tobias Linebäck, CFO and Dep. CEO performance CEO comments Agenda and Full year financials Summary and future Improved performance in SEK millions REVENUES Revenues at 208 (206)
More informationCOMMISSION DECISION. of
EUROPEAN COMMISSION Brussels, 25.11.2016 C(2016) 7553 final COMMISSION DECISION of 25.11.2016 modifying the Commission decision of 7.3.2014 authorising the reimbursement on the basis of unit costs for
More informationWhat else could you do with the time you spend on budgeting?
What else could you do with the time you spend on budgeting? Budgeting As your company evolves, you have to devote more and more time to preparing your budgets. That s why Prophix brings you. This Best
More informationThis DataWatch provides current information on health spending
DataWatch Health Spending, Delivery, And Outcomes In OECD Countries by George J. Schieber, Jean-Pierre Poullier, and Leslie M. Greenwald Abstract: Data comparing health expenditures in twenty-four industrialized
More informationSheryl T. Dacso, J.D., Dr.P.H.
Highlights of the New Health Care Reform and its Impact on the Legal Industry Presented to the Houston Metropolitan Paralegal Association November 9, 2010 Sheryl T. Dacso, J.D., Dr.P.H. sdacso@seyfarth.com
More informationAstraZeneca AB Södertälje. Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018
AstraZeneca AB 556011-7482 151 85 Södertälje Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Contents 1. Introduction... 4 Approach to disclosure
More informationSanofi-Aventis Bulgaria EOOD Methodological Note
Sanofi-Aventis Bulgaria EOOD Methodological Note INTRODUCTION Collaboration between healthcare professionals and Pharmaceutical Companies has long been a positive driver for advancements in patient care
More informationGilead Transparency Reporting Methodological Note
Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers
More informationChallenges of implementation. a regulatory perspective
Challenges of implementation of ICH Q 9 a regulatory perspective Jacques Morénas Deputy Director Inspectorate and Companies Department The French Health Products Safety Agency (AFSSAPS) telephone : 33
More informationReporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018
NV ASTRAZENECA SA BE 0400.165.679 110, rue Egide Van Ophemstraat B-1180 Brussels Belgium Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Contents
More informationYour Global Partner in International Private Medical Insurance. Expatriate Care Playbook
Your Global Partner in International Private Medical Insurance Expatriate Care Playbook AT A GLANCE 95+ Years in operation 90M Clients served by AIG companies 99.6% Fortune 500 companies AIG serves ~65,000
More informationInitial Functional Medicine (FM) Consult $475 FM follow up visits $175 Convenient Care Visit $125. Action Plan/Health Care Consult Visit $50
Cash, checks, credit cards (MasterCard, Visa, Discover) or Care Credit* are all accepted methods of payment for our services. Payment is due, in full, at the time of the scheduled appointment. When you
More informationMGMA National MGMA18 The Annual Conference September, 2018 Attendee Form
MGMA National MGMA18 The Annual Conference September, 2018 Attendee Form Title CEU Code CEUs Specialty MGMA18 The Annual Conference-PRE102 Designing and Building Processes for Value-based Healthcare 5
More informationReporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018
Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca UK Limited Registered in England No 3674842 Registered Office, 2 Kingdom Street, London,
More informationYour Company guide to a healthier future
Bupa PO Box 825 Hawthorn Victoria 3122 www.bupa.com.au Global medical plans for individuals and groups Assistance, repatriation and evacuation cover 24-hour multi-lingual helpline Your Company guide to
More informationMedicare Made Clear Answer Guide
Medicare Made Clear Answer Guide Y0066_100820_113217 File & Use 08252010 Medicare can be confusing. How do you find the best options to fit your needs? This guide has some answers that may be helpful.
More informationNote: Accredited is the highest rating an exchange product can have for 2015.
Quality Overview Permanente Accreditation Exchange Product Accrediting Organization: NCQA HMO (Exchange) Accreditation Status: Accredited Note: Accredited is the highest rating an exchange product can
More informationThe Florida International University Budget Town Hall Discussion. March 9, 2009
The Florida International University Budget Town Hall Discussion March 9, 2009 1 FLORIDA INTERNATIONAL UNIVERSITY AGENDA Direction What is the University s strategic direction? What are the state revenue
More informationSituation Regarding Implementation of Measures for the Aging Society. Fundamental Framework of Measures for the Aging Society
Chapter 2 Situation Regarding Implementation of Measures for the Aging Society Section 1 Fundamental Framework of Measures for the Aging Society The basic framework of national measures for the aging society
More informationANNUAL GENERAL MEETING
Virtus Health (ASX. VRT) ANNUAL GENERAL MEETING Wednesday 22nd November 2017 2.00pm AEDT DISCLAIMER The material in this presentation has been prepared by Virtus Health Limited ABN 80 129 643 492 ( Virtus
More informationReporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018
Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 LLC «AstraZeneca Ukraine» Legal address: Kyiv, Hvoiky str. 15/15,04080 Ukraine Actual address: Kyiv,
More informationBoard s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance.
Board Paper 2016/47 Shetland NHS Board Meeting: Shetland NHS Board Date: 4 th October 2016 Paper Title: Finance monitoring report (2016-17) to 31 August 2016 Author: Colin Marsland Job Title: Director
More informationCigna. Confirmed complaints: 5. Quality Overview. How Often Do Members Complain About This Company? Accreditation Exchange Product
Quality Overview Accreditation Exchange Product Accrediting Organization: NCQA Health Plan Accreditation (Exchange) Accreditation Status: Pending (214) Accreditation Commercial Product Accreditation Organization:
More informationBeing unprepared for a medical emergency can cost you thousands of $$ out of pocket.
Health Insurance 101 - By Linda Ziac The Caregiver Resource Center www.caregiverresourcecenter.com Being unprepared for a medical emergency can cost you thousands of $$ out of pocket. es by that there
More informationToshihiko Osada General Manager, Strategic Planning Department. Corporate Strategy. Terumo Corporation Dec 12, 2016
2 Toshihiko Osada General Manager, Strategic Planning Department Corporate Strategy Outlook: Medtech Industry Global medtech market: Forecast to grow at a CAGR of 5-6% for the next 10 years, with market
More informationCMIC HOLDINGS Co., Ltd. Consolidated Financial Results
(Note) This translation is prepared and provided for readers' convenience only. In the event of any discrepancy between this translated document and the original Japanese document, the original document
More informationContent. 05 May Memorandum. Ministry of Health and Social Affairs Sweden. Strategic Social Reporting 2015 Sweden
Memorandum 05 May 2015 Ministry of Health and Social Affairs Sweden Strategic Social Reporting 2015 Sweden Content 1. Introduction... 2 2. Delivering on the Europe 2020 objective to combat poverty and
More informationDIGITAL TRANSFORMATION ROLE IN REALIZING THE SUSTAINABLE DEVELOPMENT IN EGYPT
DIGITAL TRANSFORMATION ROLE IN REALIZING THE SUSTAINABLE DEVELOPMENT IN EGYPT CSTD Inter-Sessional Panel Meeting The impact of rapid technological change on sustainable development Vienna, 15-19 January,
More informationOPENING REMARKS BY SENATOR HUBERT H. HUMPHREY MAGAZINE PUBLISHERS ASSOCIATION WASHINGTON, D. C. MAY 14, :30 P.M. this is a necessary
OPENING REMARKS BY SENATOR HUBERT H. HUMPHREY MAGAZINE PUBLISHERS ASSOCIATION WASHINGTON, D. C. MAY 14, 1962--2:30 P.M. I am here to speak for the Adminis- ~ tration's health insurance, hospital care pro~ram
More informationHEALTHCARE: INTRODUCTION MAIN ISSUES IDENTIFIED BY THE COMMITTEE:
HEALTHCARE: The Future of Health in Estonia Multi-Sector Collaboration to Ensure Proper Business Climate, Healthy Workforce, and Attractiveness for Current & Future Investment INTRODUCTION The Estonian
More informationDaniel E. Chornous Chief Investment Officer, RBC Global Asset Management
t Membership Guide Testimonials The RIA is a leader in promoting the responsible investment industry in Canada as well as providing invaluable education and research on responsible investing issues. RBC
More informationINDUSTRY PROFILES. Health Care and Social Assistance Industry
INDUSTRY PROFILES Health Care and Social Assistance Industry July 2010 Overview: The Health Care and Social Assistance industry 1 in Alberta includes establishments and services such as: hospitals, nursing
More informationPAYING FOR THE HEALTHCARE WE WANT
PAYING FOR THE HEALTHCARE WE WANT MARK STABILE 1 THE PROBLEM Well before the great recession of 2008, Canada s healthcare system was sending out signals that it had a financing problem. Healthcare costs
More informationFederal and State Transparency Meeting Obligations and Managing Risks
Federal and State Transparency Meeting Obligations and Managing Risks Trudy Seeley, Sanofi US Diane Bieri, Arnold & Porter Sixth Annual Summit on Disclosure, Transparency and Aggregate Spend February 6,
More informationReporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018
Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca Pharma Poland Sp. z o.o. 0000117902 Postepu 14, 02-676 Warsaw Contents 1. Introduction...
More informationBoard s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance.
Board Paper 2017/04 Shetland NHS Board Meeting: Shetland NHS Board Date: 14 February 2017 Paper Title: Finance monitoring report (2016-17) to 31 December 2016 Author: Colin Marsland Job Title: Director
More informationBuilding the Healthcare System of the Future O R A C L E W H I T E P A P E R F E B R U A R Y
Building the Healthcare System of the Future O R A C L E W H I T E P A P E R F E B R U A R Y 2 0 1 7 Introduction Healthcare in the United States is changing rapidly. An aging population has increased
More informationCode of Conduct Medical Devices
Code of Conduct Medical Devices - 1st January 2012 last amended January 2018 Code of Conduct Medical Devices This translation is not legally binding. Where contradictions occur between the Dutch and English
More informationHow To Make Your Financial Plan CPA Strong
How To Make Your Financial Plan CPA Strong 11457B-302_CFF Revised CPA Brochure-PS.indd 1 Why Work With a CPA Financial Planner? Because the person who does your financial planning must also underst the
More information